Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 2/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1653274 | 0.87 | METAP2 (0.49) | ACEALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL3503447 | 0.84 | GLO1 (0.53) | ACEALDH1A1HPGDMETAP2 | |
| SCHEMBL11880817 | 0.84 | GLO1 (0.53) | ACEALDH1A1HPGDMETAP2 | |
| SCHEMBL3577970 | 0.83 | KIF11 (0.46) | ACEALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL3577967 | 0.83 | KIF11 (0.46) | ACEALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL12888845 | 0.83 | ALDH1A1 (0.51) | ACEALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL7544294 | 0.81 | CTSC (0.51) | ACEMETAP2 | |
| Benzylcysteine SCHEMBL1109643 | 0.79 | ALPI (0.58) | ACE | |
| Benzylcysteine SCHEMBL515922 | 0.79 | ALPI (0.58) | ACE | |
| Benzylcysteine SCHEMBL1927561 | 0.79 | ALPI (0.58) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | claimed |
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | ACE 1340/4885ALDH1A1 3963/4885HPGD 4277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.